"Nifuroxazide" nwa: ntuziaka maka ojiji na nzaghachi

Afọ ọsịsa bụ a mgbaàmà ji ọdịdị rụrụ stool, mụbara motility nke eriri afọ tract, omume nke erughị ala na afo ebe. Ọtụtụ mgbe a na-anaghị ekwe na-metụtara c penetration nke pathogenic microorganisms na ha multiplication na lumen nke eriri afọ tract. Ya atụmatụ bụ ọgwụgwọ nke afọ ọsịsa na ụmụ n'ihi na ngwa ngwa akpịrị ịkpọ nkụ na ọdịdị metụtara nsogbu. Ka anyị lee otú obibi na nkụda mmụọ nke a na oche na-enyemaka nke "nifuroxazide" ọgwụ n'ihi na nwa.

pharmacological atụmatụ

"Nifuroxazide" na-anọchi anya antimicrobial gị n'ụlọnga si ìgwè nke nitrofurans advantageously eji dị ka a eriri afọ antiseptik. The usoro nke edinam nke ọgwụ dabeere na mgbochi nke dehydrogenases Krebs okirikiri na cellular respiration.

Ke adianade do, "nifuroxazide" penalized Filiks nke protein njikọ na cell karịa na-penalized maka ọrụ dị mkpa nke microorganism.

pharmacodynamics

Mgbe e ji ọnụ na, ọgwụ nwere ogbenye bioavailability, i.e. nta bụghị etinye obi gị dum n'ime systemic mgbasa. The plasma ịta nwere ike achọpụtara Chọpụta nifuroxazide, na a obere ego nke na ọ na-nwetara site na excretion na unmodified ụdị. The ike nke anyụpụ na nsị. N'ihi na nke fọrọ nke nta ezu enweghị absorption ọnụego nke excretion nke ọgwụ na-adabere na dose na osisi ike nke bowel motility.

The ụdịdị dị iche iche nke edinam nke ọgwụ

Nitrofuran nkwekọrịta n'imeso "nifuroxazide" bacteriostatic edinam sredneterapevticheskih kasịnụ, na na elu doses, a bactericidal ọgwụ omume iji nwayọọ mmepe nke na-eguzogide. Iji a ọgwụ mwute ezu ukwuu nke ma gram-mma (streptococci, staphylococci penitsillinazoprodutsiruyuschie) na gram-adịghị mma microorganisms (E. coli, Salmonella, Shigella, Klebsiella, Enterobacteriaceae). Ke adianade do, ọgwụ nwere a ezighị ezi mmetụta na a dịgasị iche iche nke nje, trichomonas, giardia na fungi nke genus Candida. The ọgwụ na-anọgide na mmetụta na ọnụnọ nke abu na ndị ọzọ na ngwaahịa nke anụ ahụ ire ere ke ọnya.

"Nifuroxazide" bụ adighi ike na ọgwụgwọ nke pseudomonas na-efe efe dị ka nke ọma dị ka na-efe efe mere site microorganisms nke genus Proteus.

Egosi maka Iji "nifuroxazide" nkwadebe (ntụziaka maka ụmụaka)

Isi na-egosi maka ọgwụ dị iche iche iche iche nke nsia orunótu nke na-efe efe mere site susceptible pathogens ka ọgwụ nje. "Nifuroxazide" nye iwu na nnukwu obi nkoropụ nke a oche nke na-efe efe si na ya, ala ala mkpali bowel ọrịa na enterocolitis. Ọgwụ e nyere ọrịa na nje ọnyá (ikekwe obodo ngwa nke ọgwụ), nakwa dị ka ịwa ahụ aka na eriri afọ (n'ihi na mmiri) na na mgbagwoju ọgwụgwọ nke dysbiosis.

Ọ ga-kwuru na ihe ndị kasị ugboro ugboro ji ọgwụ maka ụmụaka ọgwụgwọ nke bowel ọrịa bụ "nifuroxazide". Ntụziaka maka ụmụaka, ma e wezụga na onunu ogwu yiri n'ihi na ndị okenye.

Dosing na Administration

Ngwa agwọ ọrịa rụrụ n'agbanyeghị nri oriri. Maka ọgwụgwọ nke ndị okenye na ụmụaka mgbe afọ asaa ọgwụ na-ewere 1 mbadamba (200 mg) atọ ma ọ bụ anọ ugboro n'ụbọchị. Nke a dose kwekọrọ na otu òkè nke 5 ml nke a nkwusioru ma ọ bụ sirop "nifuroxazide". Ntuziaka maka ojiji maka ụmụaka na ndị okenye na-atụ aro na a ga-anọgide na-3-4 ụbọchị mgbe normalisation nke a oche na-ewere ọgwụ ọjọọ. The ọgwụgwọ ekwesịghị gafere a izu. Mgbe ọgwụ adighi ike karịrị oge obibia ọgwụ ga-enyocha.

N'ihi na ụlọ akwụkwọ ọta akara ụmụ, na onunu ogwu ga-ebelata ka 100-150 mg otu dose nke ọgwụ "nifuroxazide". Sirop maka ụmụaka bụ ihe magburu onwe ọgwụgwọ nhọrọ. N'ihi ya multiplicity itinye n'aka-anọgide n'otu. Ọ bụrụ na ọgwụ na ụdị a sirop na aka e nwere ike ịbụ ọkara a mbadamba nkume nke 200 mg anwụrụ nwayọọ n'etiti abụọ tablespoons nke ntụ ntụ anọgidesi na-enye nwa ahụ na obere mmiri ma ọ bụ mmiri ara. Na niile ndị ọzọ, ọ na-atụ aro iji mmiri mmiri "nifuroxazide" (nkwusioru maka ụmụaka).

mmetụta

Mgbe na-eji nitrofurans ìgwè nke ọgwụ ọjọọ ndị emekarị mere oghom Jeremaya mere si digestive tract, nke na-ejikọrọ ozugbo na saịtị nke edinam nke ọgwụ. Mgbe anata ọgwụ "nifuroxazide 'n'ihi na nwa e nwere ihe ize ndụ nke dyspeptic ọrịa, cholestasis, ịba ọcha n'anya. Na a ala ruo n'ókè nke puru nwere ike a na-egosi na ọgwụ na-hypersensitive mmeghachi omume ndị ọrịa na-eso onye ahụ nke ọgbụgbọ, vomiting, abdominal mgbu, afọ ọsịsa. Na nke ikpeazụ ahụ, a nta nkpasu-iwe nke mgbaàmà kwesịrị ịkwụsị omume, n'ihi na mmetụta ọjọọ nke ọsọ na na-metụtara mmalite nke ọgwụ edinam. Na ọnụnọ nke oké mgbaàmà na-arịa ọrịa nke n'ozuzu ọnọdụ onye ọrịa na-anata ọgwụ ga-kwụsịrị.

Ekwesighi mmetụta nke ọgwụ na Central ụjọ usoro akara ọdịdị neuritis. Nfụkasị Jeremaya egosipụta onwe ha dị ka omume nke akpụkpọ ọkụ ọkụ, pruritus, urticaria, pustulosis. Na oké ikpe nwere ike ime ka hypersensitivity Jeremaya mere, gụnyere anaphylactic ujo na angioedema. The ọgwụ na-adịkarịghị esonyere ọrịa nke hematopoietic usoro.

Special ntuziaka maka inweta ọgwụ

Cheta na ọgwụ na-eji "nifuroxazide" ọgwụ kwesịrị ịbụ ogologo oge karịa 7 ụbọchị. Na omume nke iso afọ ọsịsa, mgbaàmà nke a na-adịghị nyeere ruo ụbọchị atọ, ọ dị mkpa iji cheekwa ozo ọgwụgwọ si eme kwupụta ọgwụ nje. Bụrụ na nke oké afọ ọsịsa na akpịrị ịkpọ nkụ mgbaàmà nke na-enwe yiri na oru "nifuroxazide" jide rehydration ọgwụ na concomitant symptomatic ọgwụgwọ.

The nkwadebe na-agụnye lactose, otú ọrịa na-ata ahụhụ si na ọrịa nke mgbaze nke umi, ngwa nke ọgwụ iji belata ma ọ bụ kpam kpam kwụsị. Mgbe na-ewere "nifuroxazide" adịghị atụ aro n'ihi na ndị ọzọ ọnụ na mmadụ iji belata irè, n'ihi na ọnụnọ nke sorption Njirimara nke nọ n'ọrụ umi. Mgbe iji agwọ ọrịa na-contraindicated mmanya oriri, dị ka nke a pụrụ iduga disulfiramopodobnyh Jeremaya na-ebu ndị ọrịa nke Central ụjọ usoro (ụzụ na-ada na ntị), anụ hyperemia, tachycardia, ụjọ nke egwu.

Dị ka ukara ọmụma na ọgwụ ọjọọ, "nifuroxazide" (ntuziaka), nkwusioru sirop maka ụmụaka na ike belata ọdịdị oghom Jeremaya mere na akụkụ nke eriri afọ.

Jiri n'oge ime na lactation

Ihe àmà doro anya na-egosi banyere ihe ize ndụ nke ọgwụ n'oge ime na lactation, ọ dịghị. Nyere na "nifuroxazide" na-adịghị etinye obi gị dum na lumen nke eriri afọ tract na ọ dịghị banye n'ime mmiri ara, nzube nke ọgwụ bụ omume ma ọ bụrụ na ndị nwere uru ndị nne nke ahụ ahụ dị elu karịa onye mmetụta nke nwa ebu n'afọ.

Nsi na ovadozu

N'ihi na ala bioavailability n'ime ihe mgbaàmà nke na nsi na-amaghị ama. Na elu doses ọgwụ na-atụ aro gastric lavage na ozugbo ọgwụgwọ maka ruru eru enyemaka ahụike.

ntọhapụ Ụdị

Na-emepụta ọgwụ ahịa "nifuroxazide" dị ka a nkwusioru maka onu ochichi (na 200 ma ọ bụ 220 mg nke nọ n'ọrụ umi ke 5 ml nke nkwusioru, vial 90 ml), mbadamba maka onu ojiji (100 ma ọ bụ 200 mg kwa 1 mbadamba) ma ọ bụ Capsule (200 mg kwa 1 Capsule). Onye ọ bụla ndidi nwere ike họrọ kwesịrị ekwesị ntọhapụ ụdị.

Na ihe ụdị ịzụta "nifuroxazide" Ọtụtụ? Sirop maka ụmụaka ndị ọzọ na-ewu ewu n'ihi na ụmụaka ndị ọzọ susceptible ka nsia-efe efe.

Synonyms

The ọgwụ na-dịnụ n'okpuru aha "Enterofuril", "Ertsefuril" n'ụdị capsules (100 ma ọ bụ 200 mg) na nkwusioru maka onu ochichi nwere 5 ml 200 mg nke nọ n'ọrụ umi (nifuroxazide). Ntuziaka maka ojiji maka analogues nke ụmụaka adịghị iche ukwuu si mbụ. Otú ọ dị, tupu n'itinye ọgwụ ọ ka ga-nlezianya atụle.

"Nifuroxazide" maka ụmụ: reviews

The ọgwụ na-abụghị nanị na-eji na ụmụaka, ma omume nke esịtidem Medicine. Fọrọ nke nta niile reviews na nke "nifuroxazide" nwere nti ụmụ. Nke a bụ n'ihi ya nrụpụta na ọgwụgwọ nke iche iche iche iche nke ọrụ na-enwe nsogbu nke eriri afọ tract, nakwa dị ka na ọnụnọ nke adaba onunu ogwu forms nke ọgwụ ka a nkwusioru na a sirop.

Ke adianade do, "nifuroxazide 'n'ihi na nwa bụ a pụtara mma ọgwụ, nke na-eduga ya nile iji na-adakarị omume.

ọgwụgwụ

"Nifuroxazide 'n'ihi na nwa bụ ndị kasị dị irè ọgwụ ọjọọ na-enyere gị aka idi afọ ọsịsa nke na-efe efe si malite. Security ochichi nke ọgwụ ruru ya ala bioavailability na elu arụmọrụ - edinam naanị na lumen nke eriri afọ tract. Dị ka ukara ọmụma na ọgwụ ọjọọ, "nifuroxazide" (ntuziaka) nkwusioru maka ụmụaka na sirop na-họọrọ iche-iche. Mbadamba, dị ka a na-achị, na-ahọpụta site okenye.